Ardent Health, Inc. (NYSE:ARDT) Receives $19.30 Average PT from Brokerages

Ardent Health, Inc. (NYSE:ARDT) has earned a consensus rating of “Moderate Buy” from the thirteen analysts that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, three have issued a hold rating and nine have issued a buy rating on the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $19.30.

Several equities analysts have issued reports on ARDT shares. Wall Street Zen raised shares of Ardent Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 9th. KeyCorp lowered their price objective on Ardent Health from $24.00 to $20.00 and set an “overweight” rating for the company in a research report on Thursday, August 7th. Bank of America downgraded Ardent Health from a “neutral” rating to an “underperform” rating and dropped their target price for the stock from $15.50 to $14.60 in a research note on Wednesday, July 16th. Weiss Ratings upgraded Ardent Health from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, October 24th. Finally, JPMorgan Chase & Co. lowered their price target on Ardent Health from $18.00 to $15.00 and set a “neutral” rating for the company in a report on Monday, August 11th.

Ardent Health Stock Performance

ARDT stock opened at $14.43 on Wednesday. Ardent Health has a one year low of $10.10 and a one year high of $17.95. The firm has a market cap of $2.07 billion, a price-to-earnings ratio of 7.97, a PEG ratio of 6.39 and a beta of 0.44. The company has a debt-to-equity ratio of 0.66, a quick ratio of 2.00 and a current ratio of 2.13. The firm has a 50-day simple moving average of $13.88 and a two-hundred day simple moving average of $13.35.

Ardent Health (NYSE:ARDT) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.30 by $0.22. Ardent Health had a net margin of 4.11% and a return on equity of 16.66%. The firm had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.54 billion. On average, equities analysts forecast that Ardent Health will post 1.23 EPS for the current fiscal year.

Institutional Trading of Ardent Health

Large investors have recently bought and sold shares of the stock. Vanguard Group Inc. raised its holdings in shares of Ardent Health by 368.9% in the first quarter. Vanguard Group Inc. now owns 1,330,635 shares of the company’s stock worth $18,296,000 after buying an additional 1,046,845 shares during the last quarter. Goldman Sachs Group Inc. increased its position in shares of Ardent Health by 1,684.9% in the 1st quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock valued at $10,558,000 after acquiring an additional 724,841 shares during the period. Ameriprise Financial Inc. raised its stake in Ardent Health by 75.6% in the 2nd quarter. Ameriprise Financial Inc. now owns 1,634,822 shares of the company’s stock worth $22,332,000 after acquiring an additional 703,739 shares during the last quarter. SageView Advisory Group LLC lifted its position in Ardent Health by 367.2% during the 2nd quarter. SageView Advisory Group LLC now owns 790,663 shares of the company’s stock worth $10,800,000 after acquiring an additional 621,430 shares during the period. Finally, Nuveen LLC purchased a new stake in Ardent Health during the 1st quarter valued at about $6,010,000.

About Ardent Health

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.